Nomura Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48.2M Buy
794,909
+22,681
+3% +$1.32M 0.12% 179
2025
Q4
$41.7M Sell
772,228
-57,208
-7% -$2.75M 0.11% 204
2025
Q3
$37.4M Sell
829,436
-130,290
-14% -$6.08M 0.1% 217
2025
Q2
$44.4M Buy
959,726
+147,999
+18% +$7.26M 0.12% 187
2025
Q1
$49.5M Sell
811,727
-452,345
-36% -$26.4M 0.15% 153
2024
Q4
$71.5M Sell
1,264,072
-20,072
-2% -$1.12M 0.22% 102
2024
Q3
$66.4M Buy
1,284,144
+243,108
+23% +$11.4M 0.2% 110
2024
Q2
$43.2M Buy
1,041,036
+4,371
+0.4% +$196K 0.15% 149
2024
Q1
$56.2M Buy
1,036,665
+65,074
+7% +$3.31M 0.2% 113
2023
Q4
$49.9M Buy
971,591
+59,486
+7% +$3.12M 0.21% 119
2023
Q3
$52.9M Buy
912,105
+61,811
+7% +$3.79M 0.25% 95
2023
Q2
$54.4M Buy
850,294
+35,937
+4% +$2.41M 0.25% 94
2023
Q1
$56.4M Sell
814,357
-301,756
-27% -$21.3M 0.3% 79
2022
Q4
$80.3M Sell
1,116,113
-150,954
-12% -$11.4M 0.47% 46
2022
Q3
$90.1M Sell
1,267,067
-144,344
-10% -$10.5M 0.57% 34
2022
Q2
$109M Sell
1,411,411
-173,895
-11% -$13.2M 0.68% 23
2022
Q1
$116M Buy
1,585,306
+95,519
+6% +$6.41M 0.63% 24
2021
Q4
$92.9M Buy
1,489,787
+327,324
+28% +$19.2M 0.47% 39
2021
Q3
$68.8M Buy
1,162,463
+5,394
+0.5% +$355K 0.39% 60
2021
Q2
$77.3M Buy
1,157,069
+80,543
+7% +$5.25M 0.45% 46
2021
Q1
$68M Sell
1,076,526
-32,467
-3% -$2.02M 0.43% 49
2020
Q4
$68.8M Buy
1,108,993
+55,676
+5% +$3.42M 0.46% 50
2020
Q3
$63.5M Buy
1,053,317
+94,681
+10% +$5.7M 0.49% 46
2020
Q2
$56.4M Buy
958,636
+406,345
+74% +$24.3M 0.48% 49
2020
Q1
$30.8M Buy
552,291
+52,988
+11% +$3.24M 0.32% 73
2019
Q4
$32M Buy
499,303
+10,874
+2% +$623K 0.29% 78
2019
Q3
$24.8M Buy
488,429
+11,382
+2% +$535K 0.24% 95
2019
Q2
$21.6M Sell
477,047
-12,351
-3% -$575K 0.21% 98
2019
Q1
$23.3M Buy
489,398
+3,256
+0.7% +$162K 0.23% 95
2018
Q4
$25.3M Buy
486,142
+208,646
+75% +$11.2M 0.28% 83
2018
Q3
$17.2M Buy
277,496
+12,509
+5% +$742K 0.17% 125
2018
Q2
$14.7M Sell
264,987
-6,651
-2% -$359K 0.15% 134
2018
Q1
$17.2M Buy
271,638
+7,853
+3% +$505K 0.19% 113
2017
Q4
$16.2M Buy
263,785
+7,318
+3% +$458K 0.19% 118
2017
Q3
$16.3M Sell
256,467
-16,832
-6% -$983K 0.21% 114
2017
Q2
$15.2M Buy
273,299
+27,442
+11% +$1.49M 0.2% 114
2017
Q1
$13.4M Buy
245,857
+10,332
+4% +$567K 0.19% 125
2016
Q4
$13.8M Sell
235,525
-5,622
-2% -$307K 0.25% 98
2016
Q3
$13M Sell
241,147
-4,102
-2% -$263K 0.23% 105
2016
Q2
$18M Sell
245,249
-2,286
-0.9% -$162K 0.34% 75
2016
Q1
$15.8M Buy
247,535
+34,417
+16% +$2.17M 0.3% 86
2015
Q4
$14.7M Buy
213,118
+350
+0.2% +$23.1K 0.28% 102
2015
Q3
$12.6M Buy
212,768
+6,534
+3% +$415K 0.25% 108
2015
Q2
$13.7M Sell
206,234
-1,120
-0.5% -$73.8K 0.25% 109
2015
Q1
$13.4M Sell
207,354
-1,310
-0.6% -$82K 0.24% 117
2014
Q4
$12.4M Sell
208,664
-25,060
-11% -$1.41M 0.22% 118
2014
Q3
$11.9M Buy
233,724
+5,480
+2% +$274K 0.21% 109
2014
Q2
$11.1M Sell
228,244
-32,920
-13% -$1.62M 0.2% 123
2014
Q1
$13.6M Buy
261,164
+6,940
+3% +$369K 0.25% 107
2013
Q4
$13.5M Sell
254,224
-39,197
-13% -$2M 0.24% 110
2013
Q3
$13.6M Sell
293,421
-83,474
-22% -$3.66M 0.26% 109
2013
Q2
$16.8M Buy
+376,895
New +$16.4M 0.33% 69

Other funds holding BMY

Nomura Asset Management's BMY Position: Q1 2026 in Review

Nomura Asset Management increased its Bristol-Myers Squibb (BMY) stake by 2.9% in Q1 2026, buying an estimated $1.32M and bringing the position to 794,909 shares worth $48.2M. The position accounts for 0.12% of the portfolio, ranked #179.

Nomura Asset Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $116M in Q1 2022. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Nomura Asset Management held 794,909 shares of Bristol-Myers Squibb worth $48.2M as of Q1 2026.
  • Nomura Asset Management bought 22,681 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.32M.
  • Bristol-Myers Squibb made up 0.12% of Nomura Asset Management's portfolio in Q1 2026, its #179 holding.
  • Nomura Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Nomura Asset Management's Bristol-Myers Squibb position peaked at $116M in Q1 2022.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Nomura Asset Management's 13F filing for Q1 2026, filed 11 May 2026.